OTCMKTS:CYDY

Cytodyn Stock Insider Trading

etoro logo Buy CYDY
*Your capital is at risk
$0.276
-0.0143 (-4.93%)
At Close: Jun 03, 2026

Cytodyn Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 70.4M and sold 3.96M CYDY shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
100.00
Buy 70.4M shares
Sell 3.96M shares
86% Buy Activity
Moderate Positive Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
Mar 20, 2026
Buy
Non-qualified stock option (right to buy)
A-Award
Blok Tyler
Chief Legal Officer
Officer 3 249 794
Value: $909.9K
Mar 20, 2026
Buy
Non-qualified stock option (right to buy)
A-Award
Brunke Karen J
Director
Director 574 385
Value: $160.8K
Mar 20, 2026
Buy
Non-qualified stock option (right to buy)
A-Award
Dunlap Ryan
Director
Director 574 385
Value: $160.8K
Mar 20, 2026
Buy
Non-qualified stock option (right to buy)
A-Award
Simes Stephen M
Director
Director 574 385
Value: $160.8K
Mar 20, 2026
Buy
Non-qualified stock option (right to buy)
A-Award
Urbach Tanya Durkee
Director
Director 574 385
Value: $160.8K
Mar 20, 2026
Buy
Non-qualified stock option (right to buy)
A-Award
Ndhlovu Lishomwa C
Director
Director 574 385
Value: $160.8K
Mar 20, 2026
Buy
Non-qualified stock option (right to buy)
A-Award
Lalezari Jacob P
Chief Executive Officer
CEO / President 4 874 691
Value: $1.36M
Mar 20, 2026
Buy
Non-qualified stock option (right to buy)
A-Award
Hoffman Robert E.
Chief Financial Officer
C-Suite Officer 4 874 691
Value: $1.36M
May 15, 2025
Buy
Non-qualified stock option (right to buy)
A-Award
Hoffman Robert E.
Chief Financial Officer
C-Suite Officer 1 000 000
Value: $410.0K
May 15, 2025
Buy
Common Stock
J-Other
Hoffman Robert E.
Officer
Officer 0
Value: $0
May 15, 2025
Buy
Common Stock
J-Other
Hoffman Robert E.
Officer
Officer 0
Value: $0
May 15, 2025
Buy
Non-qualified stock option (right to buy)
A-Award
Hoffman Robert E.
Chief Financial Officer
C-Suite Officer 1 000 000
Value: $410.0K
Oct 28, 2024
Buy
Non-qualified stock option (right to buy)
A-Award
Urbach Tanya Durkee
Director
Director 800 000
Value: $104.0K
Oct 28, 2024
Buy
Non-qualified stock option (right to buy)
A-Award
Simes Stephen M
Director
Director 800 000
Value: $104.0K
Oct 28, 2024
Buy
Non-qualified stock option (right to buy)
A-Award
Ndhlovu Lishomwa C
Director
Director 800 000
Value: $104.0K
Oct 28, 2024
Buy
Non-qualified stock option (right to buy)
A-Award
Lalezari Jacob P
Chief Executive Officer
CEO / President 3 000 000
Value: $390.0K
Oct 28, 2024
Buy
Non-qualified stock option (right to buy)
A-Award
Dunlap Ryan
Director
Director 800 000
Value: $104.0K
Oct 28, 2024
Buy
Non-qualified stock option (right to buy)
A-Award
Brunke Karen J
Director
Director 800 000
Value: $104.0K
Oct 28, 2024
Buy
Non-qualified stock option (right to buy)
A-Award
Blok Tyler
Chief Legal Officer
Officer 1 250 000
Value: $162.5K
Oct 28, 2024
Buy
Non-qualified stock option (right to buy)
A-Award
Blok Tyler
Chief Legal Officer
Officer 1 250 000
Value: $162.5K
Oct 28, 2024
Buy
Non-qualified stock option (right to buy)
A-Award
Brunke Karen J
Director
Director 800 000
Value: $104.0K
Oct 28, 2024
Buy
Non-qualified stock option (right to buy)
A-Award
Dunlap Ryan
Director
Director 800 000
Value: $104.0K
Oct 28, 2024
Buy
Non-qualified stock option (right to buy)
A-Award
Lalezari Jacob P
Chief Executive Officer
CEO / President 3 000 000
Value: $390.0K
Oct 28, 2024
Buy
Non-qualified stock option (right to buy)
A-Award
Ndhlovu Lishomwa C
Director
Director 800 000
Value: $104.0K
Oct 28, 2024
Buy
Non-qualified stock option (right to buy)
A-Award
Simes Stephen M
Director
Director 800 000
Value: $104.0K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT CYTODYN INC
Cytodyn
CytoDyn Inc. operates as a late-stage biotechnology company. The company focuses on developing treatments for multiple therapeutic indications based on leronlimab, a novel humanized monoclonal antibody targeting the CCR5 receptor. Its Leronlimab is in a class of therapeutic monoclonal antibodies designed to address unmet medical needs in the areas of human immunodeficiency virus (HIV), cancer, immunology, and novel coronavirus disease (COVID-19)....
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE